Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study

•No standard chemotherapy exists for recurrent cervical cancer patients who respond poorly to platinum administration.•Metronomic chemotherapy is a low-toxicity treatment and can maintain quality of life.•Low-dose oral cyclophosphamide and bevacizumab (CPA-BEV) chemotherapy shows promising results in recurrent cervical cancer.